avapro has been researched along with Bonnevie-Ullrich Syndrome in 1 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Bonnevie-Ullrich Syndrome: This syndrome that was originally observed by Ullrich, and designated as identical to TURNER SYNDROME, related the webbing of the neck, loose skin and other anomalies of the syndrome to accumulation of fluid in the embryo starting at the head and dispersing to the extremities (as observed by Bonnevie in mice). Commonly observed at birth in Turner Syndrome and NOONAN SYNDROME; EDEMA of the extremities usually recedes by one year and is an early sign of Turner syndrome, especially in female neonates.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Duration of treatment during pregnancy among women who had adverse fetal outcomes was 26." | 2.44 | Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature. ( Choi, JS; Han, JY; Nava-Ocampo, AA; Velázquez-Armenta, EY; Yang, KM, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Velázquez-Armenta, EY | 1 |
| Han, JY | 1 |
| Choi, JS | 1 |
| Yang, KM | 1 |
| Nava-Ocampo, AA | 1 |
1 review available for avapro and Bonnevie-Ullrich Syndrome
| Article | Year |
|---|---|
Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature.
Topics: Abortion, Spontaneous; Adult; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Female; H | 2007 |